Advancements in assistance from artificial intelligence include ambient listening to take notes during physician and patient conversations.
Congenital malalignment syndrome is a nail disorder caused by the lateral rotation of the nail matrix.
Pearl E. Grimes, MD, discusses the evolving treatment paradigm for vitiligo, highlighting the role of FDA-approved topical ruxolitinib and its impact on management strategies.
Investigators compared these outcomes due to limited research in the space, with previous surveys suggesting care disparities.
Waibel shared pearls in laser therapy and other scar treatment modalities in her talks at the American Academy of Dermatology Annual Meeting.
The rates of discontinuation due to inefficacy or adverse events for biosimilars and originators of etanercept and adalimumab were similar, according to an analysis of a prospective registry.
The survey conducted by Almirall included participants in the US and Europe.
Pulsed dye lasers are now being used for several different dermatologic conditions.
Psoriasis specialists evaluate strategies for integrating emerging therapies into existing treatment protocols and conclude by addressing persistent gaps in current psoriasis management approaches.
There are many innovative and exciting developments coming to the dermatology space, both energy-based devices and injectables.
Vd1-gd T cells, a rare type of immune cell, have been found to potentially predict how likely it is that certain patients with advanced skin cancer will be responsive to treatment via immunotherapy, according to recently published research.
The WHO underscores the significance of addressing scabies as a neglected skin disease, especially in regions with limited health care access.
This expert review explores the multifaceted causes of female hair loss—hormonal imbalances, inflammation, nutrient deficiencies, aging, and oxidative stress—and explores non-pharmaceutical interventions.
Precision measurements are necessary to improve the current therapeutic armamentarium in pigmentary disorders.
Katherine Economy, MD, discusses the challenges and opportunities of treating pregnant patients with dermatologic conditions, emphasizing the importance of comprehensive medication reviews, patient-centered decision-making, and the need for including pregnant patients in clinical trials.
Brad Glick, DO, MPH, discusses common challenges clinicians may encounter with photodynamic therapy (PDT) and offers resolution strategies, while also sharing insights on the skin conditions and patient populations where PDT has proven to be a successful treatment option.
Miller is presenting 3 sessions at the 2023 Fall Clinical Dermatology Conference for PAs and NPs.
An expert in the management of skin conditions provides an overview of a 20-year-old male diagnosed with atopic dermatitis, discussing key insights from a round table discussion. The conversation focused on effective management strategies, best practices for prior authorization approvals, and the significance of treatment vehicles.
John Strasswimmer, MD, PhD comments on the impressive utility of both vismodegib and sonidegib in patients with advanced basal cell carcinoma and Jonathan S Zager, MD, FACS, FSSO provides his insight into the clinical utility of both of these treatments.
Social media is fraught with misinformation. Pharmacists play a key role in breaking through the fallacies with facts and education on skin care.
What we know about monkeypox in pregnancy, including treatment recommendations, vaccination, and postpartum care.
Researchers from the University of Michigan and Almirall found that the profibrotic fibroblast response in HS can be modulated through inhibition of the Hippo pathway.
Psoriasis specialists evaluate strategies for integrating emerging therapies into existing treatment protocols and conclude by addressing persistent gaps in current psoriasis management approaches.
Tirbanibulin (Klisyri, Almirall) has been approved by the U.S. Food and Drug Administration (FDA) for the topical treatment of actinic keratosis on the face or scalp.
There are barriers to telehealth adoption that physicians must overcome to realize the technology’s promise.